Source: Annual Congress 2013 –COPD treatment
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Alves, F. Lundgren, C. Caribé, I. Secundo, S. Marrocos, J. Accioly, M. Lima (Recife, Brazil). Pneumococcal vaccination: Effects on exacerbation of COPD. Eur Respir J 2013; 42: Suppl. 57, 3688

Member's Comments

No comment yet.

Related content which might interest you: Comparison of efficacy of grippe vaccination and broncho vaxom administration in COPD patients Source: International Congress 2015 – Different data in COPD Year: 2015 Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13) Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Identification of nasal virus infection in patients with COPD exacerbations Source: International Congress 2014 – COPD: points to ponder Year: 2014 Clinical efficacy of pneumococcal conjugate vaccine in patients with chronic airway disease Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 Analysis of the Effect of pneumococcal vaccination in patients with COPD in combination with bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Treatment of infection in COPD exacerbations Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases Year: 2014 Impact of mucolytic treatment on COPD exacerbations Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Pneumococcal vaccine in steroid-dependent COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Etiological structure from sputum of patients with exacerbation of COPD Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Pneumonia risk in COPD patients on long term inhaled corticosteroids – Data from the European COPD audit<% Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Evolution of influenza vaccination coverages in Spanish patients with asthma or chronic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 144s Year: 2004 Distinguishing features of pneumonia and exacerbations in COPD Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models Year: 2015 Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Pneumonic and non-pneumonic exacerbations of COPD: Systemic inflammatory response and clinical characteristics Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014 Pneumonia or exacerbation of COPD? Source: Eur Respir Monogr 2015; 69: 185-196 Year: 2015